PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

5 ways to recruit sorely needed patients for Alzheimer’s clinical trials involving therapeutics

The demand is especially great for asymptomatic individuals of all races and ethnicities.

Whole-body PET image reveals body's immune response to COVID

In the study, patients who had recovered from an COVID infection were injected with a small amount of the 89Zr-labeled radiotracer before undergoing a uExplorer PET/CT scan.

neuroblastoma prognosis

18F-FDG PET/CT radiomics nomogram provides detailed insight into neuroblastoma

Better risk stratification can improve clinical decision making and better outcomes, experts involved in the study explained in EJR.

New PET imager cleared for U.S. sales

A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.

MRI confirmed as gold standard for pre-biopsy detection of prostate cancer—but that’s ‘not the end of the story’

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

Big private payer reverses course on cardiac PET/CT coverage

One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality. 

CMS initiates official review of PET scan limit for patients with Alzheimer's

"Clinical study protocols may involve more than one PET [amyloid-beta] scan per patient,” the CMS announcement said.

lung cancer pulmonary nodule chest

Preoperative PET/CT imaging linked with better survival in advanced lung cancer

PET/CT imaging in these patients increases overall survival depending on the cancer’s stage, with those diagnosed with stage 3A and 3B NSCLC appearing to benefit the most from the exam.